Company: TELO
Filing Date: 2025-11-20
Form Type: 8-K
Source: 0001493152-25-024491
Chunk: 0

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01(d) Financial
Statements and Exhibits.

(d) Exhibits

  Exhibit                                                             
     17.1      Resignation                                            
      104      Cover Page Interactive Data File (embedded within the  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                TELOMIR PHARMACEUTICALS, INC.                               
  Dated: November 20, 2025      By:                                /s/                      
                                Name:                              Erez Aminov              
                                Title:                             Chief Executive Officer